(
571
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Advances in allergen immunotherapy I
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
BAT in clinical practice. Is it possible?
-
Basophil activation test results change in birch pollen sensitized patients during first season of immunotherapy
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Benefits of engaging with patients in clinical trials and decision-making
-
Biologicals in asthma – from clinical trials to real life
-
Biologicals in asthma – from clinical trials to real life
-
Challenges in clinical allergy
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Cutting edge allergen immunotherapy
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Flash Talks on allergen immunotherapy
-
Flash talks on allergen Immunotherapy I
-
Flash talks on clinical immunology
-
Flash talks on food allergy and immunotherapy
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Immunotherapy in severe asthma (AIT)
-
Immunotherapy to food allergy
-
Improving patient care with allergen immunotherapy (AIT): Lessons learned from randomised control trials (RCT) and real world evidence (RWE) studies
-
Is specific immunotherapy useful in atopic dermatitis?
-
Molecular allergology in daily clinical practice
-
New Perspectives on Allergen Immunotherapy
-
New Perspectives on Allergen Immunotherapy
-
Omics – a novel tool in clinical trials
-
Oral food challenges thresholds for clinical reactions
-
Oral immunotherapy in Food Allergy. What is the consensus?
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Safety and prediction of allergen immunotherapy
-
Standardisation of Allergen Immunotherapy products and Legal Considerations
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
The clinical burden of cow’s milk allergy in childhood – a retrospective cohort study
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
-
What do clinical trials and real world tell us about allergy and asthma treatment?
Show more Event Resources (36)Show Less-
-
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
-
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
-
AllergoOncology: Microbiota in allergy and cancer – A European Academy for Allergy and Clinical Immunology position paper
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer – a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic procedures
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
-
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
-
Eosinophils – from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives – A report of the European Academy of Allergy and Clinical Immunology (EAACI)
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
-
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology task force
Show more Position Papers (20)Show Less-
-
“Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
-
Allergen composition of preparations translate into clinical outcomes of AIT
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Best in both worlds – Demonstrating long-term effectiveness of allergy immunotherapy in the real world
-
Clinical Cases in discussion: 3 patients, 3 experts & 1 solution
-
Clinical puzzles: Precision diagnostics in personalized medicine – Discover the connection
-
Expanding AIT evidence with new phase III clinical data in children with respiratory allergy
-
Expansion of Hydrolysed Rice Formula for Infants with Cow’s Milk Allergy: Considerations for Clinical Practice
-
How can I use food allergy diagnostic tools in my daily clinical practice?
-
How do HMO modulate the immune system in infants with CMPA? emerging evidence and clinical implications.
-
Optimising AIT clinical practice: the patient, the evidence, and the future
-
Patients’ perspective : a must have for the future of Allergen Immunotherapy
-
Raising paediatric awareness through growing evidence for allergy immunotherapy – optimise the treatment of children suffering from respiratory allergy
-
Setting a new standard for grass subcutaneous immunotherapy
-
Targeting eosinophils in severe asthma: real-world data and clinical remission
-
Allergen immunotherapy with allergoid-mannan conjugates: from basic science to clinical research
Show more Sponsored Symposia (14)Show Less-
-
Aeroallergen immunotherapy before five years of age and elderly
-
Allergen Immunotherapy and Biologicals
-
Allergen immunotherapy and co-evaluation of COVID-19 vaccines
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
Eosinophilic esophagitis and allergen immunotherapy
-
European Academy of Allergy and Clinical Immunology Task Force on HES: towards a personalized patient-centered care
-
Harmonization of clinical outcomes of efficacy in Food-AIT trials
-
Health economics of allergen immunotherapy
-
How EAACI recommendations on ocular allergy diagnosis and treatment are applied in real life clinical practice: an international multidisciplinary survey
-
Immunopharmacology: non-biological therapeutic approaches in allergy and clinical immunology
-
Joint-Task Force Proposal for Clinical Practice Recommendations on Environmental Greenness and Allergic Diseases
-
Minimal Clinically Important Difference (MCID) of clinical endpoints in AIT
-
Nocebo effect of allergen immunotherapy
-
The use of omic sciences in asthma and allergy clinical practice
-
Validation of Clinical endpoints in AIT (with MASK technology)
Show more Task Forces (13)Show Less-
-
COVID-19 Pandemic and allergen immunotherapy – an EAACI survey
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
-
SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development 
-
Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID‐19
-
Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical service
-
The younger the milder clinical course of COVID-19 – even in infants? 
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention
Show more Covid-19 (5)Show Less-
Website
Collapse
-
12 months retrospective real-life study on the clinical course of CRSwNP and respiratory function in patients with EGPA treated with biological drugs
-
300 IR 5-grass pollen sublingual immunotherapy tablet for allergic rhinoconjunctivitis: A systematic review and meta-analysis of randomised studies
-
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
-
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
-
80% reduction of required sample size in clinical trials by eDiary monitoring
-
A Novel Mutation of MYOF in Hereditary Angioedema: the First Two Case Reports in Asia and Analysis of Clinical Characteristics
-
A Point-of-Care Diagnosis of Wheat-Dependent Exercise-Induced Anaphylaxis: The Clinical Utility of Novel Gliadins Skin Test
-
A case report of Oxacillin induced Steven-Johnson-Syndrome: a clinical experience
-
A clinical case of Erythema multiforme in pediatric patient
-
A comparison of conventional vs cluster updosing venom immunotherapy in children in a tertiary hospital
-
A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant
-
ALK – Expanding AIT evidence with new phase III clinical data in children with respiratory allergy
-
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
-
Abatacept to induce remission of peanut allergy during oral immunotherapy (ATARI trial): baseline peanut-specific T cell responses of participants
-
Absence of alpha-tryptase isoforms is associated with less severe adverse events during peanut-oral immunotherapy
-
Achieving Remission with Peanut Sublingual Immunotherapy
-
Active immunotherapy with recombinant Bet v 1
-
Adherence to venom immunotherapy : a french monocentric retrospective study
-
Adult Diet: The immunesupportive diet in clinical practice
-
Advances in Allergen Immunotherapy
-
Advances in Allergen Immunotherapy (AIT)
-
Advances in Immunotherapy
-
Advances in Oral Immunotherapy
-
Advancing AIT in the clinical management of children with respiratory allergy
-
Allergen Immunotherapy
-
Allergen Immunotherapy
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Allergen Immunotherapy for the prevention of respiratory allergy
-
Allergen Immunotherapy in the Republic of Kazakhstan
-
Allergen immunotherapy
-
Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid
-
Allergen immunotherapy 1
-
Allergen immunotherapy 2
-
Allergen immunotherapy 3
-
Allergen immunotherapy 4
-
Allergen immunotherapy 5
-
Allergen immunotherapy 6
-
Allergen immunotherapy 7
-
Allergen immunotherapy in food allergy, what’s new?
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years
-
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
-
Allergic, but still want them: A Mix Pet Dander Immunotherapy
-
Allergy Therapeutics – Setting a new standard for grass subcutaneous immunotherapy
-
Alpha-gal syndrome in patient infected with Ascaris lumbricoides: a possible causal role of exposure to parasitic antigens for galactose-a-1,3-galactose sensitization and elicitation of clinical reactivity
-
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
-
Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years
-
Analysis of immunological and cellular tolerance biomarkers during bee venom immunotherapy
-
Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy
-
Antioxidant pine nut protein hydrolysate as a therapeutic oral immunotherapy agent in a murine model of pine nut allergy
-
Application of allergen standardization in allergen-specific immunotherapy (AIT)
-
Artificial Intelligence approaches for advancing drug development and clinical applications
-
Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Assessing long-term clinical and immunological evolution of Portuguese Patients with LTP Syndrome
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
AstraZeneca – Transforming severe asthma respiratory care: the clinical experience
-
Atypical clinical cases of fixed drug eruptions due to radiological contrast media
-
B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy
-
Basic and clinical immunology
-
Basophil activation test as a predicting tool for effective Pru p 3 sublingual immunotherapy response in lipid transfer protein allergy
-
Best candidate for allergen-specific immunotherapy
-
Biologicals as adds on in oral immunotherapy for IgE mediated food allergy
-
Biomarkers of tolerance in clinical trials
-
Birch Rust: Unveiling a Novel Fungal Allergen in Seasonal Airway Allergy Symptoms – Insights from the First Clinical Cohort in Northern Norway
-
Blocking antibodies from food immunotherapy unravelled at the molecular level
-
Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment
-
Build-Up of Wasp Venom Immunotherapy with Alutard-Depot SQ during Supply Shortage: A Retrospective Case Series
-
Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort
-
Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis
-
Challenge accepted: Results from the pivotal Grass Phase III clinical trial
-
Characterising Adult Legume Allergy in Clinical Practice
-
Childhood mastocytosis: challenges in clinical practice
-
Chronic Spontaneous Urticaria Patients in Latvia: Epidemiological and Clinical Characteristics
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Clinical Application of Exosome KL-6 Detection in Respiratory Diseases
-
Clinical Characteristics and Natural Course of Chronic Inducible Urticaria in a Pediatric Cohort
-
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
-
Clinical Characterization of a Group of Patients with Suspected Hereditary alpha-Tryptasemia
-
Clinical Evaluation of Allergic Diseases in Pediatric Patients Diagnosed with Cutaneous Mastocytosis: A Retrospective Study
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs
-
Clinical Impact of Long-Term Prophylaxis De-escalation with Lanadelumab in Hereditary Angioedema Type I and II
-
Clinical Outcomes and IgA Deficiency in Pediatric Patients: A Retrospective Study in a Tertiary Hospital
-
Clinical Phenotype in allergy to Brassicaceae and in-vitro diagnostic approaches
-
Clinical and Allergological Profile of Children and Adolescents With Ocular Allergy In Brazil
-
Clinical and Immunologic Phenotype of Patients with SMAD4 Gain-of-Function Mutations
-
Clinical and Translational Allergy
-
Clinical and Translational Allergy
-
Clinical and atopic features of patients with primary eosinophilic colitis: an Italian multicentre study
-
Clinical and histological differences between choanal polyps in children and adults: analysis of a 15-year series of patients treated at our institution
-
Clinical and histopathologic response following empiric food elimination diet in children with eosinophilic gastritis
-
Clinical and immunological characterization of patients with allergy to Hymenoptera venom in a county Hospital of Tolosaldea, Gipuzkoa, Spain
-
Clinical and laboratory features of children at risk of local allergic rhinitis
-
Clinical and laboratory features of patients with non-hereditary angioedema – a preliminary report of 37 cases
-
Clinical and molecular profiles in patients allergic to Amaranthaceae
-
Clinical case of development anaphylaxis to cow`s milk proteins
-
Clinical case: Patient with Inherited epidermolysis bullosa and eosinophilic esophagitis
-
Clinical cases of non-IgE mediated food allergy: from pratice to theory
-
Clinical characteristics and risk factors of allergic diseases in children after liver transplantation
-
Clinical characteristics of mastocytosis in Poland based on Polish Registry of Mastocytosis
-
Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment
-
Clinical evidence of a Reversed Enzyme Immuno Assay and an Allergy Lateral Flow Assay for the quantitative determination of specific IgE to different allergens
-
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
-
Clinical experience with targeting TSLP: first-line biologic use
-
Clinical experience with targeting TSLP: reducing patient burden of disease
-
Clinical history seen with different hypersensitivity reactions
-
Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP
-
Clinical improvement with mepolizumab after endoscopic nasal polyposis surgery in a patient with polyposis
-
Clinical manifestations and cross-reactions with cockroaches of Formosan subterranean termite (Coptotermes formosanus) and Asian subterrabea termite (Coptotermes gestroi)
-
Clinical perspectives in chronic urticaria: from etiology to severity and prognosis
-
Clinical phenotypes of Common variable immunodeficiency disorders (CVID) among adult Egyptian patients
-
Clinical phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Clinical profile of children and adolescents with ocular allergy in Brazil
-
Clinical trials
-
Clinical trials
-
Clinical trials in food allergy
-
Clinical trials in immune tolerance
-
Clinical trials on Asthma and Rhinitis
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
Clinical validation of an environmental exposure chamber in the diagnosis of allergic respiratory disease
-
CoMiSS™ data in presumed healthy infants, how does this strengthen our clinical practice?
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Comprehensive Analysis of Kiwi Allergy: Sensitization Patterns, Clinical Profiles, and Molecular Patterns using ISAC Testing
-
Comprehensive Analysis of Kiwi Allergy: Sensitization Patterns, Clinical Profiles, and Molecular Patterns using ISAC Testing
-
Comprehensive study on clinical characteristics of acute urticaria
-
Comprehensive study on clinical characteristics of acute urticaria
-
Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey
-
Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey
-
Cytometric biomarkers, clinical phenotype, and complications of common variable immunodeficiency – study from specialised Centre for primary immunodeficiencies in Martin, Slovakia
-
DBV Technologies – Epicutaneous route: an innovative potential approach to food immunotherapy
-
DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy
-
Dairy products and its clinical relevance in a series of Alpha gal allergic patients
-
Deciphering the Clinical Significance of Very-High IgE Levels (≥1000 U/mL) Among Adult Patients: a Population-based Study of 283,406 Subjects
-
Delving deeper in allergen immunotherapy
-
Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)
-
Der p 23 quantification in a HDM allergoid and its clinical relevance
-
Descriptive study of the evolution of patients after oral immunotherapy with milk at the Hospital Universitario Fundación Alcorcón
-
Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy
-
Developing and validating clinical models to identify candidates for allergic rhinitis pre-exposure prophylaxis
-
Development and Validation of a Clinical Risk Score to Predict Pediatric Atopic Dermatitis in Utero
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy
-
Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma
-
Discovering new horizons in allergen immunotherapy
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
EAACI & NIAID Joint Symposium : Harnessing the Potential of Endotyping Data to Predict Clinical Outcomes in Allergic Disease
-
EGPA: a clinical case in real life
-
Early immunotherapy with aeroallergens and impact on future allergy
-
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
-
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
-
Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission
-
Effect of allergen – specific immunotherapy on PFS symptoms
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis
-
Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study
-
Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study
-
Efficacy and Safety of Hymenoptera Venom Immunotherapy
-
Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis
-
Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR
-
Efficacy of virus-like particle (VLP)-based immunotherapy in a mouse model of HDM allergy
-
Egg Allergy in Pediatric Patients: Clinical Profiles, Sensitization and Dietary Implications
-
Emerging insights into food allergy mechanisms and clinical management
-
Endpoints in clinical trials
-
Eosinophilic esophagitis: clinical approach
-
Eosinophilic esophagitis: clinical approach
-
Eosinophilic systemic diseases: clinical characterization and efficacy of anti il5/il5-r therapy in a single center italian cohort
-
Epicutaneous Immunotherapy with Peanut Allergy
-
Epidemiology and Clinical Features of Fish Allergy
-
Epitope specific antibody profiling and future clinical applications in food allergy
-
Evaluation of Clinical and Demographic Characteristics in Children with Aero-Allergen Sensitization: A Study Based on Skin Prick Test Results
-
Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy
-
Evaluation of the clinical benefit of a pollen and allergy app in Augsburg, Southern Germany: a stratified, controlled intervention study
-
Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children
-
Evaluation of total Immunoglobulin D in sublingual immunotherapy for allergic rhinitis
-
Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy
-
Expansion of allergen-specific type 2 memory B cells with an altered phenotype after immunotherapy for bee venom or ryegrass pollen allergy
-
Exploration of clinical outcomes for children with and without an antibiotic allergy reviewed by the Children’s Antimicrobial Stewardship Program: A retrospective cohort study
-
Exploring the Protective Potential: Subcutaneous Immunotherapy associated with C. acnes as a reductor of COVID-19 Severity in Older Patients – A Single-Center Observational Study
-
Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)
-
Extensive allergic contact dermatitis with distant facial and symmetrical intertriginous involvement following application of antiseptic dexpanthenol cream to the left forearm: An unusual clinical presentation
-
Fecal IgE in Peanut Allergy: Pioneering Evidence and Clinical Implications
-
Fecal IgE in Peanut Allergy: Pioneering Evidence and Clinical Implications
-
Field Stings in Patients Undergoing Hymenoptera Venom Immunotherapy in a Healthcare Area of Central Spain
-
Flash talks on Allergen Immunotherapy 1
-
Flash talks on Allergen Immunotherapy 2
-
Flash talks on Allergen Immunotherapy 3
-
Flash talks on Allergen Immunotherapy 4
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food-allergen immunotherapy : how do I get started?
-
From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?
-
Frontiers in Allergen Immunotherapy: evidence from clinical trials
-
GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Global Stage Session 3 – Successes and challenges of Immunotherapy
-
HAE On-demand Clinical Trial Landscape
-
Harmonizing clinical outcomes in food allergen immunotherapy: COFAITH EAACI Taskforce
-
High degree of desensitization after one year of early-life peanut oral immunotherapy – SmaChO Randomized Controlled Trial
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey
-
How can I use food allergy diagnostic tools in my daily clinical practice?
-
Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions
-
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
-
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
-
INTERESTING FACT: Delayed systemic allergic reactions to corticosteroids: Clinical symptoms y cross-reactivity
-
Identifying KIT D816V Mutation in Patients With Evidence of Systemic Mast Cell Activation (MCA) and Enriched for Hereditary Alpha-tryptasemia (HaT): Results From the PROSPECTOR Clinical Trial
-
IgE profiles and clinical reactivity pattern in plant-food allergy
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
Immediate hypersensitivity reactions to corticosteroids: Clinical symptoms and cross-reactivity
-
Immune mechanisms of food immunotherapy
-
Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases
-
Immunology in clinical practice
-
Immunotherapy for LTP allergy
-
Immunotherapy for food allergy. What’s new?
-
Immunotherapy in food allergy
-
Immunotherapy in the clinic
-
Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats
-
Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study
-
Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study
-
Impact of participant baseline factors on exposure-adjusted incidence of treatment-related adverse events during peanut oral immunotherapy
-
Implementing and optimising advancements in practice – real-world clinical cases
-
Indefinite immunotherapy with different extracts in systemic mastocytosis
-
Innovations in Food Allergy Immunotherapy
-
Insights from the European registry of anaphylaxis: recurrent anaphylaxis cases and clinical implications.
-
Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children
-
Intralymphatic immunotherapy of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate produced reduced medication use and symptoms: a double-blind placebo-controlled trial
-
Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial
-
Intravenous immunotherapy with Der p 1-containing nanoparticles alleviates allergic response in a murine model of allergic rhinitis
-
Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment
-
Involving patients in the research process improves the clinical resolution of trial effect
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Key clinical messages from mechanistic studies in food allergy
-
Kinetics of IgG4 after Vespula venom immunotherapy administered with an ultra-rush protocol
-
Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Long-term Follow-up After Peanut Oral Immunotherapy During Preschool Years: Lessons from the IMPACT Trial
-
Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics
-
Mepolizumab significantly reduces clinical interventions in the management of patients with CRSwNP: post hoc analysis of SYNAPSE using a composite endpoint
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model
-
Minimal persistent inflammation in chronic spontaneous urticaria patients with clinical remission
-
Minimum resources to run an immunotherapy clinic safely
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Modulation of B cell memory responses by house dust mite allergen immunotherapy
-
Molecular IgE testing in clinical routine: choosing wisely
-
Molecular allergy diagnostics in pediatric clinical practice
-
Molecular diagnostic results of patients with impaired Th17 T-cell count and clinical suspicion of Hyper-IgE syndrome
-
Molecular tools in support to walnut oral immunotherapy
-
Monitoring response to immunotherapy
-
Moving Beyond Control to On-Treatment Clinical Remission
-
Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms
-
Murine IgG1 corresponding to human IgG4 increased by subcutaneous immunotherapy suppressed activation of group 2 innate lymphoid cells
-
NOVEL MULTI-NUTS ORAL IMMUNOTHERAPY PROTOCOLS (ALPEDIA-NOITs)
-
Nasal Allergen Challenges in the clinical setting: Experience of a centre
-
Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings
-
New clinical nomenclature for CRS
-
New directions in immunotherapy and vaccinology
-
New grading of Vernal keratoconjunctivitis based on clinical profile of 1049 Vernal Keratoconjunctivitis patients
-
Nitial Experience of Long-Term Prophylaxis with Lanadelumab for Hereditary Angioedema in China: a Clinical Observation
-
Nut immunotherapy – Is it ready for prime time?
-
Ocular Cicatricial Pemphigoid, clinical and immuno-pathological aspects, is there an association with elevated IgE?
-
One-strength dose escalation using a birch pollen allergoid for subcutaneous immunotherapy is safe and well-tolerated in children, adolescents and adults
-
One-year follow-up of children who achieved sustained unresponsiveness following early oral immunotherapy for various allergens
-
Optimal endpoints for clinical trials
-
Oral Immunotherapy for Adults with Food Allergies
-
Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy
-
Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach
-
Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children
-
Oral immunotherapy in cow’s milk allergic patients
-
Oral immunotherapy protocols for milk / egg
-
Oral immunotherapy protocols for milk / egg
-
Oral immunotherapy protocols for milk / egg
-
Outcomes of Bee Re-sting After Cessation of Venom Immunotherapy
-
Outcomes of low-dose peanut food challenges in preschoolers when initiating peanut oral immunotherapy
-
Overview of Asthma On-Treatment Clinical Remission Data
-
Overview of the clinical utility of molecular allergology in food allergy diagnosis
-
Passive immunotherapy with anti-Bet v 1 mAb
-
Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)
-
Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial
-
Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens
-
Peach Allergy in Children: Connecting Molecular Sensitization Patterns to Clinical Severity
-
Perspective of healthcare professionals dealing with allergies about the importance and practical experience of clinical coding
-
Piperacillin-tazobactam Fever in Children with Cystic Fibrosis: Incidence and Clinical Features
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system
-
Pre & Post Puberty Vernal Keratoconjunctivitis – Similarities & Differences of Clinical Manifestations in 1049 patients
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Prevalence of allergic sensitization to Quercus ilex and its clinical relevance in pollen food allergy syndrome. Differences between pediatric and adult populations
-
Prognostic value of specific IgE ratios in the tolerance of oral immunotherapy with egg allergy
-
Prospective monitoring of clinical outcomes and laboratory markers of hereditary angioedema in patients on long-term prophylaxis with lanadelumab: One-year follow-up
-
Prospective, pilot, phase 1 study of iPUMP© in patients starting sublingual allergen immunotherapy (Staloral©)
-
Quinolone Hypersensitivity Investigation in a Clinical Setting
-
RHINA : Clinical Case Discussion
-
Raising the Bar in Asthma Management: On-Treatment Clinical Remission
-
Rapid clinical and immunological improvement of persistent lymphoproliferative disease in a patient with Activated PI3K Delta Syndrome (APDS)
-
Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)
-
Reactions Due to Accidental Peanut Consumption During Epicutaneous Immunotherapy for Peanut Allergy in Toddlers
-
Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet
-
Real-life experience of allergen-specific immunotherapy
-
Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg
-
Real-life experience with long-term oral immunotherapy for nut allergic children: A single center study from Luxembourg
-
Real-world clinical experience with dupilumab use in 33 children with severe atopic dermatitis
-
Recurrent angioedema with the mutation in the Myoferlin gene. Clinical observations
-
Retrospective Analysis of Fixed Drug Eruptions: Unveiling Clinical Patterns and Identifying Causative Drugs
-
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
-
Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study
-
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
-
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
-
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
-
Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review
-
Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract
-
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
-
Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study
-
Safety of subcutaneous immunotherapy with mixtures of two allergens at maximum concentration: 10 year real-world data
-
Sanofi Regeneron – On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control
-
Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab
-
Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
-
Storage proteins: clinical and molecular patterns of peanut and tree nut allergy of a pediatric portuguese population
-
Subcutaneous Allergen-specific Immunotherapy in Pediatric Age – a level II hospital experience
-
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis
-
Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy in Poland and EU
-
Successful immunotherapy with cow’s milk and omalizumab in a 24-year-old patient with extreme cow’s milk allergy
-
Sulfonamide antibiotic allergy assessment using the SULF-FAST clinical decision tool
-
Sulfonamide antibiotic allergy assessment using the SULF-FAST clinical decision tool
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience
-
The BEACON Study: A Phase 1b/2a, Dose Escalation Study of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of the c-Kit Mab Briquilimab in Adults with symptomatic Chronic Spontaneous Urticaria (CSU)
-
The PAF inhibitor Rupatadine has a positive influence on clinical and laboratory findings in patients with urticarial vasculitis
-
The Quest for Tolerance in Allergen Immunotherapy
-
The Role of Oral Food Challenges in Clinical Trials: Necessity or Redundancy?
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial
-
The SQ tree SLIT-tablet is effective and well-tolerated during the tree pollen season (birch homologous group) in children (5-17 years) – results from a global phase III clinical trial
-
The change in quality of life of adults with food allergy treated with oral immunotherapy
-
The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years
-
The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives
-
The epicutaneous route: from the concept to potential clinical applications.
-
The experience from clinical trials
-
The future of food allergy: Challenging existing paradigms of clinical practice
-
The journey to registration: challenges for allergen immunotherapy trials
-
The successful switch of Hymenoptera venom immunotherapy (VIT) to a different manufacturer
-
The utility of basophil activation testing in honey bee venom allergy diagnosis and venom immunotherapy
-
Thermo Fisher Scientific – How can I use food allergy diagnostic tools in my daily clinical practice?
-
Trained innate immunity and immunotherapy
-
Transforming severe asthma respiratory care: the clinical experience
-
Translating clinical definitions of anaphylaxis into patient advice
-
Translational tools (adaptive trial design, end points in clinical trials and registries) the EAACI Highlights
-
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
-
Understanding the Patient: Their Preferences for Venom Immunotherapy
-
Unveiling Unique Allergenic Properties Of Rapeseed Oil: A Clinical Case Study
-
Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy
-
Variables predicting clinical remission among adults with severe asthma treated with biologic agents
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Immunotherapy in children and adolescents: safety and outcome in a study group from a third level Italian center
-
Venom immunotherapy in children – do we have an age limit ? (case report)
-
Venom immunotherapy in mastocytosis
-
Why So Sensitive? Identifying New Allergic Sensitization in Patients On Subcutaneous Immunotherapy (SCIT)
-
Сytokine profile in patients with allergic rhinitis during allergen-specific immunotherapy with added vitamin D
-
Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D
-
“Picking the Harmony”: The Science Behind Immunotherapy Treatments
-
“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy
-
“Tuning In”: Patient Profiles Orchestrating Optimized Response to Immunotherapy
-
Allergen immunotherapy – Basic and clinical perspective
-
AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy
-
Clinical Assessment of Specific Immunotherapy Efficacy in Individuals with House Dust Mite-Induced Allergic Rhinoconjunctivitis
-
Clinical Characteristics of Anaphylaxis Secondary to Subcutaneous Allergen-Specific Immunotherapy in a Pediatric Hospital in Mexico
-
Clinical Evaluation of subcutaneous immunotherapy (SCIT) containing a mixture of mites, in depot polymerized formulation without dilutional effect. Results from a prospective multicenter study
-
Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis
-
Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS
-
Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained
-
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
-
ILIT.NU: Intralymphatic immunotherapy and placebo affected cSMS similarly in grass pollen allergic individuals in a large clinical trial
-
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
-
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
-
Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years
-
Key challenges in endpoints of clinical trials in AIT- Clinical vs mechanistic parameters
-
Pediatric patients undergoing immunotherapy with alternaria alternata: demographic and clinical characterization
-
Predicting clinical response to allergen-specific immunotherapy to D. pteronyssinus using serological pre-treatment parameters
-
Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid
-
Short-term benefits of sublingual immunotherapy in routine clinical practice: Patient Benefit Index by class in the observational, prospective, longitudinal study PRACTIS
-
Short-term benefits of sublingual immunotherapy in routine clinical practice: deciphering factors influencing the patient satisfaction in the observational, prospective, longitudinal study PRACTIS
-
Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml
-
TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy
-
The SQ HDM SLIT-tablet improves QoL and reduces clinical symptoms in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis – results from a global phase III clinical trial
-
The effect of the sphenopalatine ganglion acupuncture on the clinical efficacy of cluster immunotherapy in patients with allergic rhinitis
Show more Sessions (412)Show Less-
-
Albania – Albanian Society of Allergy, Asthma and Clinical Immunology (ASAACI)
-
Algeria – Algerian Society of Allergy and Clinical Immunology
-
Asia Pacific – Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
-
Australasia – Australasian Society of Clinical Immunology and Allergy Limited (ASCIA)
-
Belgium – Belgian Society for Allergy and Clinical Immunology (BelSACI)
-
Croatia – Croatian Society for Allergology and Clinical Immunology
-
Cuba – Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Czech Republic – Czech Society of Allergology and Clinical Immunology
-
France – French Society of Allergology and Clinical Immunology
-
Georgia – Georgian Association of Allergology and Clinical Immunology (GAACI)
-
Germany – German Society for Allergology and Clinical Immunology
-
Greece – Hellenic Society of Allergology and Clinical Immunology
-
Hungary – Hungarian Society of Allergology and Clinical Immunology
-
Iceland – Icelandic Society of Allergology and Clinical Immunology
-
Israel – Israel Association of Allergy and Clinical Immunology
-
Italy – Italian Society of Allergology and Clinical Immunology (SIAAIC)
-
Jordan – Jordanian Society for Allergy and Clinical Immunology
-
Kazakhstan – Kazakhstan Association of Allergology and Clinical Immunology
-
Korea – Korean Academy of Asthma, Allergy, and Clinical Immunology (KAAACI)
-
Lithuania – Lithuanian Society of Allergology and Clinical Immunology
-
North Macedonia – North Macedonian Society of Allergy and Clinical Immunology
-
Portugal – Portuguese Society of Allergology and Clinical Immunology (SPAIC)
-
Romania – Romanian Society of Allergology and Clinical Immunology (RSACI)
-
Serbia – Serbian Association for Allergology and Clinical Immunology
-
Slovakia – Slovakian Society of Allergology and Clinical Immunology
-
Spain – Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
-
Spain – Spanish Society of Allergology Clinical Immunology (SEAIC)
-
Türkiye – Turkish National Society of Allergy and Clinical Immunology
-
United Kingdom – British Society for Allergy and Clinical Immunology (BSACI)
Show more Member societies (27)Show Less-
-
EAACI’s Research and Outreach Committee (ROC): Advancing Allergy, Asthma, and Clinical Immunology Research and Care
-
Introducing The New EAACI Review: A Gateway to Cutting-Edge Research in Allergy and Clinical Immunology
-
Submit your application for the Research and Clinical Fellowships 2023
-
European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2023 is starting on Friday
-
New Clinical Guidelines for the Diagnosis of Immediate-type Food Allergies are launched
-
Study Validates Allergen Exposure Chamber for Assessing Clinical Outcomes of HDM AIT in Allergic Rhinoconjunctivitis Patients
-
Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Study Shows Promising Results for Immunotherapy Targeting Skin Cancer
Show more News (5)Show Less-